Bayforest Capital Ltd

SEC CIK: 0002048423
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by Bayforest Capital Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overview All 13F holders of DNLI Full Q2 2026 holdings

Shares (Q2 2026): 11,437
Value: $294.2K
% of portfolio: 0.3%
Quarters held: 3; Since Q4 2025

Holdings of DNLI by Bayforest Capital Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	11,437	$294.2K	0.3%	+11,370+16,970.1%	Added	Holders
Q1 2026	67	$1.29K	<0.1%	−20,366−99.7%	Reduced	Holders
Q4 2025	20,433	$337.3K	0.3%	+20,433	New	Holders